95 related articles for article (PubMed ID: 28583553)
1. Living Donor Kidney Transplantation After Brachytherapy for Prostate Cancer: Case Report.
Harada S; Ushigome H; Masuda K; Matsuyama T; Nakamura T; Koshino K; Iida T; Nobori S; Yoshimura N
Transplant Proc; 2017 Jun; 49(5):1187-1188. PubMed ID: 28583553
[TBL] [Abstract][Full Text] [Related]
2. Follow-up Survey of Donor Candidates for Living Related Kidney Transplantation With Prostate Cancer.
Hata K; Iizuka J; Hashimoto Y; Takagi T; Kondo T; Omoto K; Shimizu T; Okumi M; Inui M; Ishida H; Tanabe K
Transplant Proc; 2018 Oct; 50(8):2338-2341. PubMed ID: 30316354
[TBL] [Abstract][Full Text] [Related]
3. [A case of elderly donor in living kidney transplant after radical radiotherapy for prostate cancer].
Okamura M; Kamba T; Kanematsu A; Watanabe J; Shimizu T; Soda T; Yoshimura K; Nakamura E; Nishiyama H; Kamoto T; Ogawa O
Hinyokika Kiyo; 2009 Oct; 55(10):623-5. PubMed ID: 19926948
[TBL] [Abstract][Full Text] [Related]
4. Salvage brachytherapy for seminal vesicle recurrence after initial brachytherapy for prostate cancer: a case report.
Hori S; Tanaka N; Asakawa I; Morizawa Y; Hirayama A; Hasegawa M; Konishi N; Fujimoto K
BMC Res Notes; 2014 Oct; 7():760. PubMed ID: 25344831
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of permanent brachytherapy combined with maximal androgen blockade in local intermediated-risk prostate cancer].
Zhou Y; Li H; Yan W; Zhou Z; Chen J; Mai Z; Ji Z
Zhonghua Wai Ke Za Zhi; 2015 Apr; 53(4):257-60. PubMed ID: 26269157
[TBL] [Abstract][Full Text] [Related]
6. Prostate Specific Antigen (PSA) as Predicting Marker for Clinical Outcome and Evaluation of Early Toxicity Rate after High-Dose Rate Brachytherapy (HDR-BT) in Combination with Additional External Beam Radiation Therapy (EBRT) for High Risk Prostate Cancer.
Ecke TH; Huang-Tiel HJ; Golka K; Selinski S; Geis BC; Koswig S; Bathe K; Hallmann S; Gerullis H
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834929
[TBL] [Abstract][Full Text] [Related]
7. Influence of body mass index on biochemical outcome after permanent prostate brachytherapy.
Merrick GS; Butler WM; Wallner KE; Galbreath RW; Allen Z; Lief JH; Adamovich E
Urology; 2005 Jan; 65(1):95-100. PubMed ID: 15667872
[TBL] [Abstract][Full Text] [Related]
8. Undetectable prostate specific antigen at 6-12 months: a new marker for early success in hormonally treated patients after prostate brachytherapy.
Miller N; Smolkin ME; Bissonette E; Theodorescu D
Cancer; 2005 Jun; 103(12):2499-506. PubMed ID: 15852361
[TBL] [Abstract][Full Text] [Related]
9. Three-year results of treatment for prostate cancer with low-dose rate temporary iridium-192 brachytherapy.
Momma T; Saito S; Toya K; Yorozu A; Dokiya T; Murai M
Int J Urol; 2006 Mar; 13(3):218-23. PubMed ID: 16643612
[TBL] [Abstract][Full Text] [Related]
10. Five-year outcomes after iodine-125 seed brachytherapy for low-risk prostate cancer at three cancer centres in the UK.
Dickinson PD; Malik J; Mandall P; Swindell R; Bottomley D; Hoskin P; Logue JP; Wylie JP
BJU Int; 2014 May; 113(5):748-53. PubMed ID: 24053230
[TBL] [Abstract][Full Text] [Related]
11. High-risk prostate cancer with Gleason score 8-10 and PSA level ≤15 ng/mL treated with permanent interstitial brachytherapy.
Fang LC; Merrick GS; Butler WM; Galbreath RW; Murray BC; Reed JL; Adamovich E; Wallner KE
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):992-6. PubMed ID: 20932674
[TBL] [Abstract][Full Text] [Related]
12. Contracted bladder developing after prostate brachytherapy.
Yamada Y; Minowada S; Aruga T; Homma Y
Int J Urol; 2012 Oct; 19(10):951-3. PubMed ID: 22725658
[TBL] [Abstract][Full Text] [Related]
13. Retzius Space Preservation Technique for Robotic-Assisted Laparoscopic Radical Prostatectomy in a Kidney Transplant Patient: First Case in Thailand and Our First Experience.
Jenjitranant P; Sangkum P; Sirisreetreerux P; Viseshsindh W; Patcharatrakul S; Kongcharoensombat W
Transplant Proc; 2016 Nov; 48(9):3130-3133. PubMed ID: 27932164
[TBL] [Abstract][Full Text] [Related]
14. Brachytherapy for clinically localized prostate cancer: thirteen-year disease-free survival of 769 consecutive prostate cancer patients treated with permanent implants alone.
Ragde H; Grado GL; Nadir BS
Arch Esp Urol; 2001 Sep; 54(7):739-47. PubMed ID: 11692443
[TBL] [Abstract][Full Text] [Related]
15. Permanent prostate brachytherapy and short-term androgen deprivation for intermediate-risk prostate cancer in Japanese men: outcome and toxicity.
Yamada Y; Masui K; Iwata T; Naitoh Y; Yamada K; Miki T; Okihara K
Brachytherapy; 2015; 14(2):118-23. PubMed ID: 25304650
[TBL] [Abstract][Full Text] [Related]
16. High dose rate (HDR) brachytherapy with conformal radiation therapy for localized prostate cancer.
Deger S; Boehmer D; Roigas J; Schink T; Wernecke KD; Wiegel T; Hinkelbein W; Budach V; Loening SA
Eur Urol; 2005 Apr; 47(4):441-8. PubMed ID: 15774239
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and Feasibility of Low-Dose Rate Brachytherapy for Prostate Cancer in Renal Transplant Recipients.
Iizuka J; Hashimoto Y; Hashimoto Y; Kondo T; Takagi T; Nozaki T; Shimizu T; Akimoto T; Ishida H; Karasawa K; Tanabe K
Transplant Proc; 2016 Apr; 48(3):910-3. PubMed ID: 27234765
[TBL] [Abstract][Full Text] [Related]
18. Laparoscopic radical prostatectomy in a cadaveric renal transplant patient: first case in Thailand and the authors first experience--a case report.
Saema A; Patcharatrakul S; Kongchareonsombat W
J Med Assoc Thai; 2013 May; 96(5):633-6. PubMed ID: 23745320
[TBL] [Abstract][Full Text] [Related]
19. Long-term Follow-up of Living-Donor Kidney Transplantation after Cadaveric Lung Transplantation.
Shiotani T; Sugimoto S; Araki K; Tomioka Y; Miyoshi K; Otani S; Yamane M; Toyooka S
Acta Med Okayama; 2021 Feb; 75(1):87-89. PubMed ID: 33649618
[TBL] [Abstract][Full Text] [Related]
20. Prostate-specific antigen relapse-free survival and side-effects in 734 patients with up to 10 years of follow-up with localized prostate cancer treated by permanent iodine implants.
Prada PJ; Juan G; González-Suárez H; Fernández J; Jimenez I; Amón J; Cepeda M
BJU Int; 2010 Jul; 106(1):32-6. PubMed ID: 20067460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
